A rare and overlooked complication of chemotherapy led to an unusual healthcare challenge — loss of fingerprints. This condition, known as Adermatoglyphia, can occur due to chemotherapy-induced skin changes, resulting in fingerprint effacement. In this case, a cancer patient undergoing treatment experienced fingerprint loss, which prevented biometric authentication for government health insurance under Ayushman Bharat (Pradhan Mantri Jan Arogya Yojana).
This unexpected issue led to delays in accessing essential healthcare benefits, highlighting a gap between digital healthcare systems and real-world clinical scenarios. This case emphasizes the need for alternative authentication methods and increased awareness among healthcare providers and policymakers about chemotherapy-related fingerprint loss. Click here to know more
